By Mr Liam Stuart Acheson

Conference Presentations

Siefried K; Acheson L; Clifford B; Moller C; Brett J; Christmass M; Dunlop A; Haber P; Jutras-Aswad D; Lintzeris N; Morley K; Shoptaw S; Trivedi M; Ezard N, 2025, 'A pilot study of the safety and feasibility of oral naltrexone and bupropion for methamphetamine use disorder', presented at The 87th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD), New Orleans, USA, 14 June 2025 - 18 June 2025

Acheson L; Ezard N; Fletcher K; Clifford B; Steele M; Moses M; Siefried K, 2024, 'A heuristic for evaluating methamphetamine withdrawal treatment programs', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Siefried K; Clifford B; Acheson L; Ezard N, 2023, 'Innovations beyond BC: Lisdexamfetamine for the treatment of methamphetamine use disorder and withdrawal', presented at The 5th Annual BC Substance Use Conference, Vancouver, Canada, 20 April 2023 - 23 April 2023

Acheson LS; Gordon C; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried K, 2022, 'An exploratory analysis of actigraphy and sleep diaries in a methamphetamine withdrawal clinical trial', presented at Lisbon Addictions, Lisbon, Portugal, 23 November 2022 - 25 November 2022

Ezard N; Clifford B; Siefried K; Acheson L, 2022, 'Safety and tolerability of lisdexamfetamine for  methamphetamine dependence and withdrawal, early experience from Australia: The LiMA Trial and OLAM pilot', presented at Annual Meeting Conference of the Norwegian Association for Addiction Medicine, Bergen, Norway, 02 November 2022

Acheson L; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried K, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot safety and feasibility trial', presented at The 2022 APSAD Scientific Alcohol and Drugs Conference, Darwin, Australia, 09 October 2022 - 12 October 2022, https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13537

Siefried K; Acheson L; Williams B; Farrell M; McKetin R; Ezard N, 2022, 'OUTCOMES AND MEASURES USED IN RANDOMISED CONTROLLED TRIALS EXAMINING PHARMACOTHERAPIES FOR THE TREATMENT OF METHAMPHETAMINE WITHDRAWAL: RESULTS OF A SYSTEMATIC REVIEW', presented at The College on Problems of Drug Dependence 84th Annual Scientific Meeting, Minneapolis, USA, 11 June 2022 - 15 July 2022, https://d2p55c5k0gw6a2.cloudfront.net/wp-content/uploads/2022/07/2022-CPDD-Abstract-Book.pdf

Williams BH; Acheson LS; Farrell M; McKetin R; Ezard N; Siefried K, 2022, 'Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials', presented at RANZCP 2022 Congress, Sydney, 15 May 2022 - 19 May 2022, http://dx.doi.org/10.1177/00048674221088686

Siefried K; Arunogiri S; Brett J; McKetin R; Acheson LS; Knock E; Farrell M; Dunlop A; Lintzeris N; Ezard N, 2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Back to profile page